Retatrutide

Retatrutide is a triple hormone receptor agonist currently being researched for its interaction with metabolic regulation, appetite signaling, and energy expenditure pathways. Research has focused on its combined activity at GLP-1, GIP, and glucagon receptors and how these pathways may influence satiety, nutrient utilization, and body composition.

Studies have also explored Retatrutide’s relationship with metabolic flexibility, caloric intake regulation, and long-term energy balance mechanisms.

Metabolic Fat Loss Appetite

Common Research Uses

  • Appetite regulation and satiety
  • Triple incretin and metabolic signaling
  • Energy expenditure and nutrient utilization
  • Body composition and weight management

Typical Research Dosing

Weekly Range: 2-8 mg
Frequency: Once weekly
Common Cycle Length: 12–24 weeks

Subcutaneous Protocol (15 mg + 1 mL BAC = 15 mg/mL)

Phase Weekly Dose (mg) Units per Injection
Week 1 1 mg once weekly 6.67 units
Weeks 2-4 2 mg once weekly 13.3 units
Weeks 5-8 4 mg once weekly 26.7 units
Weeks 9-12 6 mg once weekly 40 units
Weeks 13+ 8 mg once weekly 53.3 units

Based on reconstitution of 15 mg with 1 mL bacteriostatic water (15 mg/mL).

Reconstitution Steps

Your Mix: 15 mg peptide + 1 mL bacteriostatic water = 15 mg/mL
  1. Prep clean: Wash hands, use a clean surface, and gather supplies.
  2. Sanitize: Alcohol swab vial stoppers and allow to air-dry.
  3. Add diluent slowly: Inject bacteriostatic water down the vial wall to reduce foaming.
  4. Mix gently: Gently swirl or roll until fully dissolved. Do not shake.
  5. Label: Write compound name, date, and concentration (mg/mL).
  6. Store appropriately: Store according to supplier guidance and maintain sterile technique.

Educational reference only

Injection Technique

General subcutaneous guidance from clinical best-practice resources.

  • Allow the peptide to reach room temperature before injection.
  • Clean the vial stopper and injection site with alcohol and allow to fully dry.
  • Pinch a small skinfold and insert the needle at a 45–90° angle into subcutaneous tissue.
  • Do not aspirate for subcutaneous injections; inject slowly and steadily.
  • Rotate injection sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.
  • Inject slowly to help minimize any stinging sensation.

This information is provided for educational reference only and reflects general clinical best practices.

How It Works

Retatrutide is a synthetic peptide designed to activate glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors simultaneously. These pathways are involved in regulating appetite, digestion, glucose metabolism, and energy expenditure.

Research suggests Retatrutide works through combined receptor activity that may support satiety signaling, influence caloric intake, and increase metabolic energy utilization. Studies have focused on how triple agonist activity may create complementary metabolic effects by targeting multiple pathways associated with appetite and nutrient balance at the same time.

At the cellular and systemic level, Retatrutide has been studied for its interaction with insulin signaling, glucagon-related energy regulation, gastric emptying pathways, and neurological signaling associated with hunger and food reward behavior. Researchers have also explored its potential role in supporting changes in body composition and metabolic efficiency.

Unlike stimulant-based metabolic compounds, Retatrutide is being researched for its hormone-mimicking mechanism centered on incretin and glucagon receptor signaling rather than central nervous system stimulation.

Commonly Reported Side Effects

  • Constipation
  • Fatigue
  • Vomiting
  • Diarrhea
  • Nausea
  • Injection site reactions

These effects are based on commonly reported research observations and may vary by individual.